Class information for: |
Basic class information |
Class id | #P | Avg. number of references |
Database coverage of references |
---|---|---|---|
204 | 52492 | 46.8 | 90% |
Hierarchy of classes |
The table includes all classes above and classes immediately below the current class. |
Cluster id | Level | Cluster label | #P |
---|---|---|---|
0 | 4 | BIOCHEMISTRY & MOLECULAR BIOLOGY//CELL BIOLOGY//ONCOLOGY | 4064930 |
204 | 3 | PROTEASOME//UBIQUITIN//UNFOLDED PROTEIN RESPONSE | 52492 |
677 | 2 | PROTEASOME//UBIQUITIN//PROTEASOME INHIBITOR | 13186 |
1195 | 2 | JNK//ERK5//MAP KINASE | 9252 |
1548 | 2 | UNFOLDED PROTEIN RESPONSE//ENDOPLASMIC RETICULUM STRESS//ER STRESS | 7418 |
1709 | 2 | C FOS//EGR 1//IMMEDIATE EARLY GENE | 6679 |
2158 | 2 | NF KAPPA B//I KAPPA B//IKK | 4991 |
3037 | 2 | KLF4//KRUPPEL LIKE FACTOR//GADD45 | 2468 |
3159 | 2 | YAP//HIPPO PATHWAY//TAZ | 2202 |
3177 | 2 | PROTEIN KINASE CK2//CK2//CASEIN KINASE 2 | 2149 |
3564 | 2 | 14 3 3 PROTEIN//14 3 3//14 3 3 SIGMA | 1319 |
3713 | 2 | A20//LAPTM4B//WWP1 | 1079 |
3833 | 2 | CITED2//BRANCHIO OCULO FACIAL SYNDROME//AP 2 ALPHA | 911 |
3893 | 2 | PRL 3//ATF3//ATF5 | 838 |
Terms with highest relevance score |
rank | Term | termType | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|---|
1 | PROTEASOME | authKW | 262586 | 3% | 32% | 1405 |
2 | UBIQUITIN | authKW | 251329 | 3% | 31% | 1398 |
3 | UNFOLDED PROTEIN RESPONSE | authKW | 165550 | 1% | 46% | 624 |
4 | CELL BIOLOGY | WoSSC | 152837 | 28% | 2% | 14955 |
5 | BIOCHEMISTRY & MOLECULAR BIOLOGY | WoSSC | 151118 | 45% | 1% | 23808 |
6 | ENDOPLASMIC RETICULUM STRESS | authKW | 142172 | 1% | 35% | 715 |
7 | ER STRESS | authKW | 136286 | 1% | 34% | 703 |
8 | PROTEIN KINASE CK2 | authKW | 110894 | 0% | 76% | 251 |
9 | NF KAPPA B | authKW | 89636 | 3% | 11% | 1475 |
10 | YAP | authKW | 85401 | 0% | 66% | 224 |
Web of Science journal categories |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | Cell Biology | 152837 | 28% | 2% | 14955 |
2 | Biochemistry & Molecular Biology | 151118 | 45% | 1% | 23808 |
3 | Oncology | 27817 | 14% | 1% | 7209 |
4 | Biophysics | 13914 | 7% | 1% | 3641 |
5 | Genetics & Heredity | 9678 | 7% | 1% | 3693 |
6 | Neurosciences | 4414 | 8% | 0% | 4194 |
7 | Developmental Biology | 4287 | 2% | 1% | 1151 |
8 | Medicine, Research & Experimental | 1524 | 3% | 0% | 1706 |
9 | Immunology | 1520 | 5% | 0% | 2392 |
10 | Chemistry, Medicinal | 1327 | 2% | 0% | 1204 |
Address terms |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | BIOCHEM | 20642 | 6% | 1% | 3036 |
2 | MED | 20141 | 24% | 1% | 12714 |
3 | GENE REGULAT SIGNAL TRANSDUCT | 18720 | 0% | 25% | 133 |
4 | CELLULAR MOL BIOCHEM 151 | 16812 | 0% | 100% | 29 |
5 | BIOCHEM MOL BIOL | 16445 | 3% | 2% | 1590 |
6 | IWAWAKI INITIAT UNIT | 15092 | 0% | 96% | 27 |
7 | HOWARD HUGHES MED | 11982 | 2% | 3% | 931 |
8 | CANC | 9536 | 2% | 2% | 1186 |
9 | CELL GROWTH PROLIFERAT | 9508 | 0% | 86% | 19 |
10 | PHARMACOL | 9318 | 4% | 1% | 1854 |
Journals |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | JOURNAL OF BIOLOGICAL CHEMISTRY | 64825 | 8% | 3% | 4279 |
2 | ONCOGENE | 43122 | 2% | 7% | 1182 |
3 | MOLECULAR AND CELLULAR BIOLOGY | 34124 | 2% | 5% | 1174 |
4 | EMBO JOURNAL | 14062 | 1% | 4% | 669 |
5 | MOLECULAR CELL | 13845 | 1% | 7% | 369 |
6 | BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS | 13194 | 3% | 2% | 1335 |
7 | CELLULAR SIGNALLING | 9522 | 1% | 6% | 274 |
8 | FEBS LETTERS | 8119 | 2% | 2% | 815 |
9 | MOLECULAR BRAIN RESEARCH | 7228 | 0% | 5% | 244 |
10 | ONCOTARGET | 7158 | 1% | 3% | 408 |
Author Key Words |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
LCSH search | Wikipedia search |
---|---|---|---|---|---|---|---|
1 | PROTEASOME | 262586 | 3% | 32% | 1405 | Search PROTEASOME | Search PROTEASOME |
2 | UBIQUITIN | 251329 | 3% | 31% | 1398 | Search UBIQUITIN | Search UBIQUITIN |
3 | UNFOLDED PROTEIN RESPONSE | 165550 | 1% | 46% | 624 | Search UNFOLDED+PROTEIN+RESPONSE | Search UNFOLDED+PROTEIN+RESPONSE |
4 | ENDOPLASMIC RETICULUM STRESS | 142172 | 1% | 35% | 715 | Search ENDOPLASMIC+RETICULUM+STRESS | Search ENDOPLASMIC+RETICULUM+STRESS |
5 | ER STRESS | 136286 | 1% | 34% | 703 | Search ER+STRESS | Search ER+STRESS |
6 | PROTEIN KINASE CK2 | 110894 | 0% | 76% | 251 | Search PROTEIN+KINASE+CK2 | Search PROTEIN+KINASE+CK2 |
7 | NF KAPPA B | 89636 | 3% | 11% | 1475 | Search NF+KAPPA+B | Search NF+KAPPA+B |
8 | YAP | 85401 | 0% | 66% | 224 | Search YAP | Search YAP |
9 | HIPPO PATHWAY | 82306 | 0% | 81% | 176 | Search HIPPO+PATHWAY | Search HIPPO+PATHWAY |
10 | CALRETICULIN | 78391 | 1% | 45% | 305 | Search CALRETICULIN | Search CALRETICULIN |
Core articles |
The table includes core articles in the class. The following variables is taken into account for the relevance score of an article in a cluster c: (1) Number of references referring to publications in the class. (2) Share of total number of active references referring to publications in the class. (3) Age of the article. New articles get higher score than old articles. (4) Citation rate, normalized to year. |
Rank | Reference | # ref. in cl. |
Shr. of ref. in cl. |
Citations |
---|---|---|---|---|
1 | HERDEGEN, T , LEAH, JD , (1998) INDUCIBLE AND CONSTITUTIVE TRANSCRIPTION FACTORS IN THE MAMMALIAN NERVOUS SYSTEM: CONTROL OF GENE EXPRESSION BY JUN, FOS AND KROX, AND CREB/ATF PROTEINS.BRAIN RESEARCH REVIEWS. VOL. 28. ISSUE 3. P. 370 -490 | 707 | 52% | 952 |
2 | PEARSON, G , ROBINSON, F , GIBSON, TB , XU, BE , KARANDIKAR, M , BERMAN, K , COBB, MH , (2001) MITOGEN-ACTIVATED PROTEIN (MAP) KINASE PATHWAYS: REGULATION AND PHYSIOLOGICAL FUNCTIONS.ENDOCRINE REVIEWS. VOL. 22. ISSUE 2. P. 153 -183 | 297 | 68% | 2398 |
3 | MENG, ZP , MOROISHI, T , GUAN, KL , (2016) MECHANISMS OF HIPPO PATHWAY REGULATION.GENES & DEVELOPMENT. VOL. 30. ISSUE 1. P. 1 -17 | 172 | 87% | 28 |
4 | VOGES, D , ZWICKL, P , BAUMEISTER, W , (1999) THE 26S PROTEASOME: A MOLECULAR MACHINE DESIGNED FOR CONTROLLED PROTEOLYSIS.ANNUAL REVIEW OF BIOCHEMISTRY. VOL. 68. ISSUE . P. 1015-1068 | 309 | 78% | 1241 |
5 | HAYDEN, MS , GHOSH, S , (2004) SIGNALING TO NF-KAPPA B.GENES & DEVELOPMENT. VOL. 18. ISSUE 18. P. 2195-2224 | 226 | 65% | 2376 |
6 | HAYDEN, MS , GHOSH, S , (2012) NF-KAPPA B, THE FIRST QUARTER-CENTURY: REMARKABLE PROGRESS AND OUTSTANDING QUESTIONS.GENES & DEVELOPMENT. VOL. 26. ISSUE 3. P. 203-234 | 235 | 65% | 452 |
7 | CARGNELLO, M , ROUX, PP , (2011) ACTIVATION AND FUNCTION OF THE MAPKS AND THEIR SUBSTRATES, THE MAPK-ACTIVATED PROTEIN KINASES.MICROBIOLOGY AND MOLECULAR BIOLOGY REVIEWS. VOL. 75. ISSUE 1. P. 50 -83 | 262 | 61% | 501 |
8 | MCCONNELL, BB , YANG, VW , (2010) MAMMALIAN KRUPPEL-LIKE FACTORS IN HEALTH AND DISEASES.PHYSIOLOGICAL REVIEWS. VOL. 90. ISSUE 4. P. 1337 -1381 | 329 | 66% | 265 |
9 | GLICKMAN, MH , CIECHANOVER, A , (2002) THE UBIQUITIN-PROTEASOME PROTEOLYTIC PATHWAY: DESTRUCTION FOR THE SAKE OF CONSTRUCTION.PHYSIOLOGICAL REVIEWS. VOL. 82. ISSUE 2. P. 373 -428 | 283 | 55% | 2238 |
10 | JOHNSON, R , HALDER, G , (2014) THE TWO FACES OF HIPPO: TARGETING THE HIPPO PATHWAY FOR REGENERATIVE MEDICINE AND CANCER TREATMENT.NATURE REVIEWS DRUG DISCOVERY. VOL. 13. ISSUE 1. P. 63-79 | 184 | 85% | 149 |
Classes with closest relation at Level 3 |